Loading data for BYSI — first visit, this takes a few seconds.
BeyondSpring Inc. (BYSI)
NasdaqCM: BYSI
· リアルタイム株価 · USD
0.72
+0.01 (1.41%)
終値時点: Aug 18, 2026, 3:48 PM
0.72
+0.00%
寄り付き前: 5:27 AM
BeyondSpring Inc. (BYSI) Stock Price, Analysis & Data
1.41% (1D)
BYSIについて
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (...
企業情報の全文
